Shenzhen YHLO Biotech Co., Ltd. (688575.SS)
CNY 16.47
(0.37%)
CNY 16.47
(0.37%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 586.79 Million CNY | 23.91% |
| 2022 | 473.54 Million CNY | 102.64% |
| 2021 | 233.68 Million CNY | -23.81% |
| 2020 | 306.71 Million CNY | 13.05% |
| 2019 | 271.31 Million CNY | 15.66% |
| 2018 | 234.58 Million CNY | 188.26% |
| 2017 | 81.38 Million CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 596.61 Million CNY | 1.67% |
| 2024 Q2 | 741.18 Million CNY | 24.23% |
| 2024 Q3 | 841.98 Million CNY | 13.98% |
| 2023 Q2 | 645.51 Million CNY | 38.64% |
| 2023 Q1 | 465.6 Million CNY | -1.68% |
| 2023 FY | 586.79 Million CNY | 23.91% |
| 2023 Q4 | 586.79 Million CNY | -10.56% |
| 2023 Q3 | 656.07 Million CNY | 1.64% |
| 2022 Q3 | 350.33 Million CNY | -28.53% |
| 2022 Q1 | 330.05 Million CNY | 41.24% |
| 2022 Q2 | 490.22 Million CNY | 48.53% |
| 2022 FY | 473.54 Million CNY | 102.64% |
| 2022 Q4 | 473.54 Million CNY | 35.17% |
| 2021 Q2 | 300.63 Million CNY | -23.32% |
| 2021 FY | 233.68 Million CNY | -23.81% |
| 2021 Q3 | 224.51 Million CNY | -25.32% |
| 2021 Q1 | 392.06 Million CNY | 27.83% |
| 2021 Q4 | 233.68 Million CNY | 4.08% |
| 2020 Q4 | 306.71 Million CNY | 0.0% |
| 2020 FY | 306.71 Million CNY | 13.05% |
| 2020 Q2 | 322.77 Million CNY | 0.0% |
| 2020 Q1 | - CNY | -100.0% |
| 2019 Q4 | 271.31 Million CNY | 0.0% |
| 2019 FY | 271.31 Million CNY | 15.66% |
| 2018 FY | 234.58 Million CNY | 188.26% |
| 2017 FY | 81.38 Million CNY | 0.0% |